Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Eckhardt

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Frontiers in Public Health|August 15, 2022
Hepatitis C virus risk among young people who inject drugsPedro Mateu-Gelabert, Nasim S Sabounchi, Honoria Guarino, et al.
Anti-Cancer Drugs|October 1, 1994
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)T J O'Rourke, G R Weiss, P New, et al.
The Annals of Pharmacotherapy|November 22, 2013
Impact of a clinical pharmacy admission medication reconciliation program on medication errors in "high-risk" patientsMitchell S Buckley, Lisa M Harinstein, Kimberly B Clark, et al.
Mucosal Immunology|January 16, 2014
Soluble CD83 ameliorates experimental colitis in miceJ Eckhardt, S Kreiser, M Döbbeler, et al.
Human Mutation|July 5, 2001
Twelve novel mutations in the tissue-nonspecific alkaline phosphatase gene (ALPL) in patients with various forms of hypophosphatasiaA Taillandier, A S Lia-Baldini, M Mouchard, et al.
Nature Physics|December 15, 2025
Cavity electrodynamics of van der Waals heterostructuresGunda Kipp, Hope M Bretscher, Benedikt Schulte, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Frontiers in Public Health|August 15, 2022
Hepatitis C virus risk among young people who inject drugsPedro Mateu-Gelabert, Nasim S Sabounchi, Honoria Guarino, et al.
Anti-Cancer Drugs|October 1, 1994
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)T J O'Rourke, G R Weiss, P New, et al.
The Annals of Pharmacotherapy|November 22, 2013
Impact of a clinical pharmacy admission medication reconciliation program on medication errors in "high-risk" patientsMitchell S Buckley, Lisa M Harinstein, Kimberly B Clark, et al.
Mucosal Immunology|January 16, 2014
Soluble CD83 ameliorates experimental colitis in miceJ Eckhardt, S Kreiser, M Döbbeler, et al.
Human Mutation|July 5, 2001
Twelve novel mutations in the tissue-nonspecific alkaline phosphatase gene (ALPL) in patients with various forms of hypophosphatasiaA Taillandier, A S Lia-Baldini, M Mouchard, et al.
Nature Physics|December 15, 2025
Cavity electrodynamics of van der Waals heterostructuresGunda Kipp, Hope M Bretscher, Benedikt Schulte, et al.
Pageof 5